Electronic cardiac medicine: present and future opportunities
- PMID: 20809436
- DOI: 10.4414/smw.2010.13052
Electronic cardiac medicine: present and future opportunities
Abstract
The second half of the 20th century witnessed a revolution in electronic medicine similar to that in pharmacology in the decades before. The advent of the implantable pacemaker, implantable cardioverter-defibrillators, cardiac resynchronisation therapies, insertable loop recorders and more, have improved diagnoses and reduced mortality and morbidity in millions of patients suffering from cardiac disease. The possibility to monitor patients continually without need for frequent office visits has the potential to reduce follow-up burden on physicians, facilitate increased use of home-based care and further improve the safety for patients. This review summarises the role of cardiac device therapies today and some of the developments which we can hope for in the nearest future.
Similar articles
-
[Active cardiac implantable electronic devices: What is possible in ambulatory health care in 2017?].Herzschrittmacherther Elektrophysiol. 2017 Sep;28(3):279-286. doi: 10.1007/s00399-017-0524-0. Epub 2017 Aug 22. Herzschrittmacherther Elektrophysiol. 2017. PMID: 28831556 Review. German.
-
[Transvenous extraction of cardioverter-defibrillator leads and pacemaker leads as a challenge in interventional cardiology in the coming decade].Kardiol Pol. 2010 Aug;68(8):891-2. Kardiol Pol. 2010. PMID: 20730718 Polish. No abstract available.
-
Access to and clinical use of cardiac implantable electronic devices and interventional electrophysiological procedures in the European Society of Cardiology Countries: 2016 Report from the European Heart Rhythm Association.Europace. 2016 Aug;18 Suppl 3:iii1-iii79. doi: 10.1093/europace/euw244. Europace. 2016. PMID: 27496955
-
Update on cardiac implantable electronic devices: from the injectable loop recorder to the leadless pacemaker, to the subcutaneous defibrillator.Minerva Cardioangiol. 2018 Dec;66(6):762-769. doi: 10.23736/S0026-4725.18.04693-5. Minerva Cardioangiol. 2018. PMID: 30468062 Review.
-
A futuristic perspective on clinical studies of cardiac resynchronization therapy for heart failure patients.Curr Opin Cardiol. 2006 Mar;21(2):78-82. doi: 10.1097/01.hco.0000203840.72902.39. Curr Opin Cardiol. 2006. PMID: 16470139 Review.
Cited by
-
A randomized study of remote follow-up of implantable cardioverter defibrillators: safety and efficacy report of the ECOST trial.Eur Heart J. 2013 Feb;34(8):605-14. doi: 10.1093/eurheartj/ehs425. Epub 2012 Dec 13. Eur Heart J. 2013. PMID: 23242192 Free PMC article. Clinical Trial.
-
Self-powered cardiovascular electronic devices and systems.Nat Rev Cardiol. 2021 Jan;18(1):7-21. doi: 10.1038/s41569-020-0426-4. Epub 2020 Sep 7. Nat Rev Cardiol. 2021. PMID: 32895536 Review.
-
Bradyarrhythmia development and permanent pacemaker implantation after cardiac surgery.North Clin Istanb. 2018 Aug 8;5(4):288-294. doi: 10.14744/nci.2017.20438. eCollection 2018. North Clin Istanb. 2018. PMID: 30859158 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical